RA Capital Healthcare Fund LP

Director, 10% owner, Artiva Biotherapeutics, Inc.; 10% owner, Adicet Bio, Inc.; Director, 10% owner, SpyGlass Pharma, Inc.; Director, 10% owner, Climb Bio, Inc.; 10% owner, Fulcrum Therapeutics, Inc.

Bought, 12 months

$62.6M

Sold, 12 months

$58.4M

Companies

Latest trade

Jul 31, 2026

Companies

Artiva Biotherapeutics, Inc.Director, 10% owner +$1.9M Adicet Bio, Inc.10% owner +$1.6M SpyGlass Pharma, Inc.Director, 10% owner +$59.0M Climb Bio, Inc.Director, 10% owner +$0.0M Fulcrum Therapeutics, Inc.10% owner −$58.4M

Trades

ARTV Bought 24,944 shares at $9.93 $0.2M Jul 31

ARTV Bought 20,824 shares at $9.99 $0.2M Jul 29

ARTV Bought 7,882 shares at $8.95 $0.1M Jul 17

ARTV Bought 152,472 shares at $8.93 $1.4M Jul 16

ACET Bought 74,751 shares at $7.27 $0.5M Feb 20

ACET Bought 74,268 shares at $7.21 $0.5M Feb 19

ACET Bought 74,577 shares at $7.04 $0.5M Feb 18

SGP Bought 3,690,000 shares at $16.00 $59.0M Feb 9

CLYM Bought 7,111 shares at $3.50 $0.0M Jan 5

FULC Sold 4,175,139 shares at $13.98 $58.4M Dec 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.